Fintel reports that on May 21, 2026, Leerink Partners initiated coverage of Opus Genetics (NasdaqCM:IRD) with a Outperform recommendation.
Analyst Price Forecast Suggests 134.32% Upside
As of May 14, 2026, the average one-year price target for Opus Genetics is $10.40/share. The forecasts range from a low of $8.08 to a high of $15.75. The average price target represents an increase of 134.32% from its latest reported closing price of $4.44 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Opus Genetics is 17MM, an increase of 42.44%. The projected annual non-GAAP EPS is -0.28.
What is the Fund Sentiment?
There are 83 funds or institutions reporting positions in Opus Genetics. This is an increase of 21 owner(s) or 33.87% in the last quarter. Average portfolio weight of all funds dedicated to IRD is 0.43%, an increase of 103.61%. Total shares owned by institutions increased in the last three months by 75.11% to 47,455K shares. 
The put/call ratio of IRD is 0.03, indicating a bullish outlook.
What are Other Shareholders Doing?
Caligan Partners holds 6,075K shares representing 8.51% ownership of the company.
Adage Capital Partners Gp, L.l.c. holds 6,030K shares representing 8.44% ownership of the company. In its prior filing, the firm reported owning 1,105K shares , representing an increase of 81.67%. The firm increased its portfolio allocation in IRD by 1,158.75% over the last quarter.
BIOS Capital Management holds 3,683K shares representing 5.16% ownership of the company. No change in the last quarter.
Balyasny Asset Management holds 2,718K shares representing 3.81% ownership of the company. No change in the last quarter.
Millennium Management holds 2,630K shares representing 3.68% ownership of the company. In its prior filing, the firm reported owning 2,003K shares , representing an increase of 23.87%. The firm increased its portfolio allocation in IRD by 194.25% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
